Infinity Pharmaceuticals Profile

2.00
USD 0.01  0.50%
70%
60%

Infinity Pharmaceuticals exotic insider transaction detected

Infinity Pharmaceuticals insider trading alert for general transaction of common stock by Kutok Jeffery, Chief Scientific Officer, on August 17, 2018. This event was filed by Infinity Pharmaceuticals with SEC on 2018-08-17. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Infinity Pharmaceuticals Summary

Infinity Pharmaceuticals (INFI) is traded on NASDAQ in USA. It is located in 784 Memorial Drive and employs 22 people. The company currently falls under 'Small-Cap' category with current market capitalization of 113.7 M. Infinity Pharmaceuticals conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 56.85 M outstanding shares of which 1.71 M shares are currently shorted by private and institutional investors with about 6.86 trading days to cover. INFINITY PHARMACE currently holds about 49.16 M in cash with (23.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.87.
Check Infinity Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 2.0HorizonTargetOdds Above 2.0
80.47%30 days 2.00 19.39%
Based on normal probability distribution, the odds of Infinity Pharmaceuticals to move above current price in 30 days from now is about 19.39% (This Infinity Pharmaceuticals probability density function shows the probability of Infinity Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Bvf IncCommon Shares15.2 M29.1 M
Vanguard Group IncCommon Shares2.2 M4.2 M
Susquehanna International Group LlpCall Options124.5 K238 K
View Infinity Pharmaceuticals Diagnostics

Selected Infinity Pharmaceuticals Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Infinity Pharmaceuticals Against Markets

Current Ratings

Infinity Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
9 
Chance of
Financial Distress (0 to 100%)
74 
Equity ratings for Infinity Pharmaceuticals are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for people with cancer in the United States. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ. It employs 22 people. more
NameInfinity Pharmaceuticals
ChairmanAdelene PerkinsView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
Business Address784 Memorial Drive
ExchangeNASDAQ
CIK Number0001113148
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.infi.com
Phone617 453 1000
CurrencyUSD - US Dollar

Did you try this?

Run Commodity Channel Index Now
   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Commodity Channel Index

Directors

Infinity Pharmaceuticals Corporate Directors
Jeffrey Berkowitz Independent Director
Norman Selby Lead Outside Independent Director
Jose Baselga Independent Director
Please also check Risk vs Return Analysis. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.